Phase 3 Study of Drug Candidate for Cervical Cancer Granted FDA Special Protocol Assessment
News
The U.S. Food and Drug Administration (FDA) has granted clinical stage biotechnology company Advaxis special approval for a Phase 3 clinical trial ... Read more